AngioDynamics Inc. has entered into a new Credit Agreement with JPMorgan Chase Bank, N.A. and its subsidiary RITA Medical Systems, LLC. Announced on May 28, 2025, the agreement establishes a $25 million secured revolving credit facility set to mature on May 28, 2027. This facility, guaranteed by RITA and secured by first priority security interests in the assets of the Loan Parties, aims to enhance financial flexibility for AngioDynamics. The company, despite being well-capitalized, views this move as prudent financial management to navigate potential working capital fluctuations, especially during its manufacturing transfer process. The agreement includes customary financial covenants and provisions, with the revolving facility subject to a borrowing base and an initial issuance cap of $2 million for letters of credit.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。